Arcturus Therapeutics Inc (ARCT): Rasio rega marang dodolan

Logo korporat perusahaan Arcturus Pharma (ARCT)

Arcturus Therapeutics' critical dependence on external CRO/CMO contractors for mRNA drug production drives its price action. The volatility of the P/S ratio visualizes this process, where the value of 11.10 reflects the metric's balance. Stability is underpinned by a US-based R&D foundation and government contracts, while the risks of a narrow portfolio are offset by royalties from global pharma partners.

ARCT: Multiplikator P/S Arcturus Therapeutics 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Arcturus Pharma (ARCT)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega arcturusrx.com|ARCT - Bagan rega target
- data kapitalisasi bursa:
Biji pasar Arcturus Pharma|ARCT - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi Saham Arcturus Therapeutics|ARCT - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku arcturusrx.com|ARCT - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Arcturus Therapeutics|ARCT - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Arcturus Corp|ARCT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Arcturus Pharma|ARCT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Arcturus Therapeutics|Rasio jangkoan perantara arcturusrx.com
- informasi bathi lan kelipatan valuasi:
ARCT - Bathi resik|Bathi mangsa ngarep Arcturus Therapeutics|ARCT - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Arcturus Therapeutics Inc|ARCT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Arcturus Pharma|ARCT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Arcturus Therapeutics|ARCT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan arcturusrx.com|ARCT - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Arcturus Therapeutics
- rincian pendapatan lan dodolan emiten:
ARCT - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan arcturusrx.com|ARCT - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Arcturus Pharma
Analisis umum perusahaan:ARCT arcturusrx.com
Produk dadi Arcturus Therapeutics

Professional asset selection is based on finding a balance between market value and actual revenue generation to exclude overvalued securities. By analyzing price-to-sales dynamics, an investor assesses the ratio of market capitalization to sales volume, which for Arcturus Therapeutics (ARCT) is critically important given the dependence of income on Japanese royalties and the efficiency of R&D cost management during the development of mRNA therapies.

Perusahaan pesaing

VRTX (vrtx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alnylam ALNY|INSM (Insmed Inc.) - Rasio rega marang dodolan|United Therapeutics Corp. - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan BMRN (BioMarin Corp)|BBIO: Multiplikator P/S|BGM Group (BGM) - Multiplikator P/S|Rasio rega marang pendapatan Cogent Biosciences, Inc.|XERS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Keros Pharma (KROS)|Kapitalisasi marang pendapatan Eton Corp ETON|Multiplikator P/S KMDA (Kamada Ltd.)|Multiplikator P/S fulcrumtx.com FULC|Abeona - Multiplikator P/S|MREO - Multiplikator P/S|Protalix (PLX) - Rasio rega marang pendapatan|Pliant Therapeutics, Inc. - Rasio kapitalisasi pasar marang pendapatan|APLT (Applied Therapeutics) - Multiplikator P/S|Kapitalisasi marang pendapatan aileronrx.com (RNTX)|Kapitalisasi marang pendapatan GELS (Gelteq Limited)|Kapitalisasi marang volume dodolan AYTU|Chemomab Therapeutics Ltd. - Kapitalisasi marang pendapatan|Multiplikator P/S SRx Health Solutions Inc SRXH|PLRZ - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan AEZS (Aeterna Zentaris)|CYTH (Cyclo Therapeutics, Inc.) - Kapitalisasi marang pendapatan|Inozyme Pharma (INZY) - Multiplikator P/S|Rasio rega marang pendapatan Reneo Pharma|COSCIENS Bio (CSCI) - Koefisien rega marang pendapatan